Base de donnée de Produits de santé homologués
| DESIGNATION | DCI | TITULAIRE AMM | PAYS D'ORIGINE | PGHT(FCFA) | N°AMM | DATE EXPIRATION AMM |
|---|---|---|---|---|---|---|
| RILIF PLUS 500mg+100mg Comprimé B/30 | PARACETAMOL + ACECLOFENAC | UMEDICA LABORATORIES PVT. LTD. | Inde | 2886.21 | G0065/12 | 2023-01-31 |
| SYNFLORIX B/1 | SEROTYPE 1 + SEROTYPE 4 + SEROTYPE 5 + SEROTYPE 6B + SEROTYPE 7F + SEROTYPE 9V + SEROTYPE 14 + SEROTYPE 18CV + SEROTYPE 19F + SEROTYPE 23F | GLAXOSMITHKLINE WEST & CENTRAL AFRICA | Turquie | 25247.78 | AMM_2018_3474 | 2023-01-31 |
| REJUNURON 500mcg+100mg Gélule B/30 | METHYCOBALAMINE + ACIDE ALPHA LIPOIQUE | FOURRTS LABORATORIES PVT. LTD | Inde | 2131.86 | AMM_2016_574 | 2023-01-30 |
| SUCRAFIL O GEL 1g+20mg Suspension buvable Fl/100 mL | SULFATE DE MAGNESIUM + OXETACAÏNE | FOURRTS LABORATORIES PVT. LTD | Inde | 708.43 | AMM_2016_466 | 2023-01-29 |
| DIFAL 50mg Comprimé B/30 | DICLOFENAC | GALENICA S.A. | Maroc | 1620.21 | 6219/03 | 2023-01-27 |
| DISMIGRAS-20 20mg Comprimé pelliculé B/30 | ROSUVASTATINE | MSN LABORATORIES PRIVATE LIMITED | Inde | 2656.63 | AMM_2018_2990 | 2023-01-26 |
| LEVOXA 500mg Comprimé pelliculé B/5 | LEVOFLOXACINE | ACTAVIS GROUP PTC | Islande | 2295.85 | AMM_2018_2988 | 2023-01-26 |
| TERBISIL 250mg Comprimé B/28 | TERBINAFINE | ACTAVIS GROUP PTC | Islande | 3935.74 | AMM_2018_2989 | 2023-01-26 |
| CEREBROFORTE 800mg Comprimé B/30 | PIRACETAM | UNIPHARMA CO - UNIVERSAL INDUSTRIAL PHARMACEUTICAL CO. | Egypte | 2597.59 | AMM_2018_2962 | 2023-01-23 |
| CYCLOGEST 400 400mg Ovule B/15 | PROGESTERONE | ACTAVIS GROUP PTC | États-Unis d'Amérique | 5214.86 | AMM_2018_2965 | 2023-01-23 |